BriaCell Therapeutics Corp.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-1.3M | $-1.3M | — | $1.7K |
| FY2021 | $-7.8M | $-7.8M | — | $2.0M |
| FY2022 | $-12.5M | $-12.5M | — | $3.1M |
| FY2023 | $-23.7M | $-23.7M | — | $2.2M |
| FY2024 | $-24.1M | $-24.6M | $456.8K | $1.8M |
| FY2025 | $-28.2M | $-28.2M | — | $656.8K |
| FY2026 | $-28.7M | $-28.8M | $127.0K | $1.1M |